Pacira Pharmaceuticals Stock Buybacks
Pacira Pharmaceuticals Stock Buybacks Chart
View Stock Buybacks for PCRX.
Start Your YCharts Pro Gold Membership.
Pacira Pharmaceuticals Historical Stock Buybacks Data
Pro Data ExportThere is no data for the selected date range.
About Stock Buybacks
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Buybacks are sometimes an indication that a company perceives their stock to be undervalued, but it is up to the investor to determine if the company is correct. Companies that are favorable to shareholders may often issue dividends and perform stock buybacks. For an example of a company that has performed a lot of stock buybacks, see Washington Post (WPO)
Learn More
View Stock Buybacks for PCRX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
PCRX Stock Buybacks Benchmarks
| Companies | |
|---|---|
| BioScrip | Go Pro |
| Neurocrine Biosciences | Go Pro |
| Lannett Company | Go Pro |
PCRX Stock Buybacks Rankings
| Overall |
79th percentile 1532 of 7590 |
| Sector |
78th percentile 141 of 651 in Healthcare |
| Industry |
80th percentile 10 of 52 in Drug Manufacturers - Major |
PCRX Stock Buybacks Range, Past 5 Years
| Minimum | Go Pro | Sep 2009 |
| Maximum | Go Pro | Sep 2010 |
| Average | Go Pro |
PCRX News
Seeking Alpha May 8